ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Nasopharyngeal Carcinoma · Treatment

What are the treatment options for nasopharyngeal carcinoma?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Nasopharyngeal Carcinoma Answer length: short, citable
Quick answer

Treatment is stage- and site-specific, and usually combines intensity-modulated radiotherapy (IMRT) as the definitive treatment — typically 33 fractions over 6–7 weeks, stage I: IMRT alone; Stage II: IMRT with or without concurrent cisplatin-based chemotherapy and locally advanced (Stage III–IVA): induction chemotherapy (gemcitabine + cisplatin or TPF) followed by concurrent chemoradiotherapy. Early-stage disease is generally treated with one modality (surgery or radiotherapy), while locally advanced disease needs combined modality treatment planned by a multidisciplinary team.

In detail

The decision is made by a tumour board including head and neck surgery, radiation oncology, medical oncology, radiology, pathology, dentistry, nutrition and speech/swallow rehabilitation. Functional outcome — speech, swallowing, breathing and appearance — is considered alongside cancer control.

Ask your team explicitly whether the goal is curative, organ-preserving or palliative, and whether a clinical trial is available. NCCN and NCI patient guidelines are a useful checklist for these questions.

  • Intensity-modulated radiotherapy (IMRT) as the definitive treatment — typically 33 fractions over 6–7 weeks
  • Stage I: IMRT alone; Stage II: IMRT with or without concurrent cisplatin-based chemotherapy
  • Locally advanced (Stage III–IVA): induction chemotherapy (gemcitabine + cisplatin or TPF) followed by concurrent chemoradiotherapy
  • Anti-EGFR (nimotuzumab) or PD-1 immunotherapy (toripalimab, camrelizumab, pembrolizumab) in selected protocols and in recurrent/metastatic disease, per regional guidelines
  • Salvage surgery or re-irradiation for local recurrence; systemic therapy for distant metastasis
  • Supportive care: nasal irrigation, mouth-opening and neck exercises, skin and oral care, nutrition and swallowing support

What this means in practice: this answer is part of the “Treatment” section of the Nasopharyngeal Carcinoma topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about nasopharyngeal carcinoma

See all 15 questions in this topic →

Sources for this answer

  1. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025
  2. Head and Neck Cancers (patient information) US National Cancer Institute · 2025
  3. Nasopharyngeal cancer statistics (GLOBOCAN 2022 country rankings) World Cancer Research Fund International · 2022
  4. Nasopharyngeal Carcinoma in Southeast Asia: Current Landscape and Future Priorities Frontiers / British Journal of Biomedical Science partnership · 2025 · 83.3% of the 120,434 global NPC cases in 2022 occurred in Asia.
  5. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  6. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionHow is nasopharyngeal carcinoma diagnosed and staged? Next question →What is the prognosis for nasopharyngeal carcinoma?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.